Since last November, APMA has been working with our Novitas Carrier Advisory Committee (CAC) representatives to clarify problematic language in Novitas’ Mycotic Nail Debridement Local Coverage Determination (LCD). As a result of the work of APMA and the CAC representatives, Novitas has changed the language, releasing a new LCD with an effective date of August 16, 2018. Under this new LCD, if the patient qualifies under “mycotic nail debridement” and debridement is performed without concomitant pharmacologic therapy, mycologic confirmation is expected.Read More
CMS released the hardship exception application for MIPS-eligible clinicians for the 2018 performance period on August 8. There are three main categories of exception application types: PI Hardship Exception; Special Status Clinicians; and Extreme and Uncontrollable Circumstances.Read More
As APMA has reported, CMS released its 2019 Medicare Physician Fee Schedule Proposed Rule [CMS-1693-P] that, if finalized, would require podiatrists to use different E/M codes from all other Medicare physicians. The codes would reimburse at a significantly lower rate.Read More
APMA, with American Association of Orthopaedic Surgeons (AAOS) and American Orthopaedic Foot and Ankle Society (AOFAS), submitted a joint letter to CMS on July 18 that urged CMS to reduce the burdens placed on physicians by Medicare Advantage Organizations (MAOs), and to increase transparency in MAO coding and payment policies.Read More
Coding for Arthroscopies
September 20, 2018
On September 20, at 8 p.m. ET, APMA will present another installment of its Surgical Coding webinar series, "Coding for Arthroscopies." Michael King, DPM, and Luke Hunter, DPM, will present.